Effectiveness of anti-IgE and anti-IL-5 treatment in step 5 asthma patients.

被引：0
|
作者：
Saji, Junko [1 ]
Muraoka, Hiromi [1 ]
Nishimoto, Eriko [1 ]
Matsuzawa, Shin [2 ]
Okamoto, Mariko [2 ]
Inoue, Teppei [2 ]
Handa, Hiroshi [2 ]
Nishine, Hiroki [2 ]
Inoue, Takeo [2 ]
Miyazawa, Teruomi [2 ]
Mineshita, Masamichi [2 ]
机构：
[1] Kawasaki Municipal Tama Hosp, Div Resp Dis, Dept Internal Med, Kawasaki, Kanagawa, Japan
[2] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp Dis, Kawasaki, Kanagawa, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA1131
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1131
引用
收藏
页数：2
相关论文
共 50 条
  • [31] ANTI-IGE AND ANTI-IL5 THERAPY FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
    Solans-Laque, Roser
    Fonseca, Eva
    Luis Callejas-Rubio, Jose
    Martinez-Zapico, Aleida
    Solanich, Xavier
    Miguel Lopez-Dupla, Jesu
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 812 - 813
  • [32] Anti-IgE and asthma
    Frew, AJ
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (02) : 117 - 118
  • [33] Anti-IL-5 treatments are a useful adjunct for treatment of chronic severe asthma
    Nixon, Gillian M.
    McNamara, David G.
    Armstrong, David S.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2024, 60 (10) : 613 - 615
  • [34] A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma
    Busse, William W.
    Ring, Johannes
    Huss-Marp, Johannes
    Kahn, Jean-Emmanuel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (04) : 803 - 813
  • [35] Clinical and Lung Function Outcomes After Anti-IgE or Anti-IL5 Therapy in Severe Asthma
    AlShareef, Saad
    McDonald, Christine F.
    Lee, Joy
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 209 - 217
  • [36] Exacerbations of Severe Asthma While on Anti-IL-5 Biologics
    Bhalla, A.
    Zhao, N.
    Rivas, D. D.
    Ho, T.
    de Liano, Perez L.
    Mukherjee, M.
    Nair, P.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2020, 30 (05) : 307 - 316
  • [37] Mepolizumab (anti-IL-5) reduces exacerbations in patients with refractory eosinophilic asthma
    Pavord, Ian
    Korn, Stephanie
    Howarth, Peter
    Bleecker, Eugene
    Buhl, Roland
    Keene, Oliver
    Ortega, Hector
    Pascal, Pascal Chanez
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [38] Anti-interleukin (IL) 5 but not anti-IgE treatment prevents airway inflammation and hyperresponsiveness (AHR).
    Hamelmann, E
    Cieslewicz, G
    Joetham, A
    Schwarze, J
    Gelfand, EW
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 488 - 488
  • [39] Sputum cell counts and FeNO levels in patients treated with anti-IgE and anti-IL-5 /IL-5R: Evidence for a dissociation between sputum eosinophil counts and FeNO levels
    Sabbe, Mare
    Schleich, Florence
    Bougard, Nicolas
    Moermans, Catherine
    Henquet, Monique
    Guissard, Francoise
    Sanschez, Carole
    Paulus, Virginie
    Louis, Renaud
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [40] The use of anti-IgE in the treatment of allergic asthma
    Bush, RK
    MEDICAL CLINICS OF NORTH AMERICA, 2002, 86 (05) : 1113 - +
12345